{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:16:55Z","timestamp":1785907015448,"version":"3.56.0"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,10,15]]},"DOI":"10.2169\/internalmedicine.7382-21","type":"journal-article","created":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T22:07:52Z","timestamp":1619388472000},"page":"3257-3260","source":"Crossref","is-referenced-by-count":4,"title":["Hydroxyzine-induced Torsade de Pointes in a Patient with Complete Atrioventricular Block"],"prefix":"10.2169","volume":"60","author":[{"given":"Kaito","family":"Koshino","sequence":"first","affiliation":[{"name":"Division of Cardiology, Shimane University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Endo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimane University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhide","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimane University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimane University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Shimane University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lee BH, Lee SH, Chu D, et al. Effects of the histamine H<sub>1<\/sub> receptor antagonist hydroxyzine on hERG K<sup>+<\/sup> channels and cardiac action potential duration. Acta Pharmacol Sin 32: 1128-1137, 2011.","DOI":"10.1038\/aps.2011.66"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wang WX, Ebert SN, Liu XK, Chen YW, Drici MD, Woosley RL.  &quot;Conventional&quot; antihistamines slow cardiac repolarization perfused (Langendorff) feline hearts. J Cardiovasc Pharmacol 32: 123-128, 1998.","DOI":"10.1097\/00005344-199807000-00019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Schlit AF, Delaunois A, Colomar A, et al. Risk of QT prolongation and torsade de pointes associated with exposure to hydroxyzine: re-evaluation of an established drug. Pharma Res Per 5: e00309, 2017.","DOI":"10.1002\/prp2.309"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Materan CA, Oliva ED, Rodriguez DF, Afonso JH. QT interval prolongation and torsade de pointes: synergistic effect of flecainide and h1 receptor antagonist. J Pharmacol Pharmacother  7: 102-105, 2016.","DOI":"10.4103\/0976-500X.184776"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Roden DM. Drud-induced prolongation of the QT interval. N Engl J Med 350: 1013-22, 2004.","DOI":"10.1056\/NEJMra032426"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gowda RM, Khan IA, Wilbur SL, Vasavada BC, Sacchi TJ. Torsade depointes: the clonical considerations. Int J Cardiol 96: 1-6, 2004.","DOI":"10.1016\/j.ijcard.2003.04.055"},{"key":"7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.hrthm.2005.07.017","volume":"2","author":"EK Heist","year":"2005","unstructured":"7. Heist EK, Ruskin JN. Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians. Heart Rhythm 2: S1-S8, 2005.","journal-title":"Heart Rhythm","ISSN":"https:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"8","unstructured":"8. Letsas KP, Efremidis M, Filippatos GS, Sideris AM. Drug-induced long QT syndrome. Hellenic J Cardiol 48: 296-299, 2007."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ayad RF, Assar MD, Simpson L, Garner JB, Schussler JM. Cause and management of drug-induced long QT syndrome. Proc (Bayl Univ Med Cent) 23: 250-255, 2010.","DOI":"10.1080\/08998280.2010.11928628"},{"key":"10","unstructured":"10. Galiano L, Hingle N, Kurlin K, Michaud V, Dow P, Turgeon J. Mechanisms and clinical relevance of drug-induced long QT syndrome: block of hERG, drug metabolism and drug transport in the human heart. Ann Pharmacol Pharm 5: 1176, 2020."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tamargo J, Caballero R, Gomez R, Valenzuela C, Delpon E. Pharmacology of cardiac potassium channels. Cardiovasc Res 62: 9-33, 2004.","DOI":"10.1016\/j.cardiores.2003.12.026"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K<sup>+<\/sup> current: differential sensitivity to block by class III antiarrhythmic agents. Cardiovasc Drug Rev 96: 195-215, 1990.","DOI":"10.1085\/jgp.96.1.195"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakaya H, Tohse N, Takeda Y, Kanno M. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. Br J Pharmacol 109: 157-163, 1993.","DOI":"10.1111\/j.1476-5381.1993.tb13546.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Napolitano C, Schwartz PJ, Brown AM, et al. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threating arrhythmias. J Cardiovasc Electrophysiol 11: 691-696, 2000.","DOI":"10.1111\/j.1540-8167.2000.tb00033.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/20\/60_7382-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T03:30:57Z","timestamp":1634355057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/20\/60_7382-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":14,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7382-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"article-number":"7382-21"}}